Israel’s NeuroRx has demonstrated a 50% reduction in symptoms of depression and a 75% reduction in suicidal feelings in a small trial of its Cyclurad treatment in combination with ketamine on treatment-resistant patients with bipolar disorder.

http://www.israel21c.org/hope-for-people-with-bipolar-depression/